Teva Pharma Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
7 result(s) found, displaying 1 to 7
-
Australian Public Assessment Report (AusPAR)Radicava (edaravone) was approved to treat adults with a diagnosis of amyotrophic lateral sclerosis who are independent in activities of daily living with normal respiratory function and where treatment is initiated within two years of disease onset.
-
Australian Public Assessment Report (AusPAR)AUSTEDO (deutetrabenazine) for the treatment of chorea associated with Huntington's disease and tardive dyskinesia in adult.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Fremanezumab
-
Australian Public Assessment Report (AusPAR)
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Reslizumab
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Levonorgestrel / ethinyloestradiol
-
Australian Public Assessment Report (AusPAR)